Illustrates How Biofinity Energys® Contact Lenses Can Help with Eye Tiredness and Dryness Associated with Digital Device Use
SAN RAMON, Calif., August 24, 2020—With an unprecedented number of people continuing to work from home and students beginning the next school year, time spent using digital devices has soared.1 To help educate the public about the impact of extended screen time on the eyes—and how Biofinity Energys® contact lenses are designed to help—CooperVision has launched a new digital campaign targeting consumers.
The campaign features a series of social media and banner ads appealing to those with busy lifestyles and increased screen time. Clicking through will take visitors to an all new BiofinityEnergys.com, where they can learn more about the prevalence of digital eye strain, the symptoms and ways to combat them. The site also provides an overview of Biofinity Energys® contact lenses, which are designed to help people’s eyes better adapt so they can seamlessly shift focus between digital devices and offline activities for a more comfortable lens-wearing experience. To help drive them into nearby eye care practices, those who are interested in trying the lens can fill out a form for free trial lenses.
To complement the ads, CooperVision has partnered with Jessica Naziri, a digital lifestyle and technology expert, writer, and speaker who will develop and share a series of blog posts, videos, and social media content about how Biofinity Energys® can help with eye tiredness and dryness associated with digital device use.
“Over the last six months, the world has changed dramatically. Many of the daily activities that typically take place face-to-face—meetings, classes, and social engagements—have become virtual to comply with current social distancing guidelines. This means that most of us are undoubtedly looking at screens more than ever before,” said Michele Andrews, OD, Senior Director of Professional and Academic Affairs, North America, CooperVision. “Eye care professionals are telling us that as a result of this lifestyle shift, patients are also dealing with new eye health challenges. Through this campaign, we hope to educate them about why their eyes suddenly feel the way they do—and how their eye doctors can help.”
As part of this effort, CooperVision is also conducting nationwide research to further examine trends in digital device use relative to eye health during the COVID-19 pandemic. Results will be shared in the coming weeks.
For more information about Biofinity Energys®, visit https://coopervision.com/practitioner/our-products/biofinity-family/biofinity-energys.
# # #
1 The Vision Council. Published by International Review of Ophthalmic Optics. Digital Eye Strain in the USA. REF: https://www.pointsdevue.com/article/digital-eye-strain-usa-overview-vision-council
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism, presbyopia and childhood myopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
McDougall Communications for CooperVision, Inc.
firstname.lastname@example.org or +1-585-434-2148